A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments

NCT04418765 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

892

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Eptinezumab
DRUG: Placebo

Sponsor

H. Lundbeck A/S